Dermata Therapeutics, Inc. (DRMA)
NASDAQ·Healthcare·Biotechnology
$1.17
-5.26%
Mkt Cap $903.06K
Analyst Ratings
No recent rating data.
Price Target (1 analysts)
$6.00
Range $6.00 – $6.00
Implied Upside
+412.8%
Consensus $6.00 vs current $1.17
NASDAQ·Healthcare·Biotechnology
$1.17
-5.26%
Mkt Cap $903.06K
No recent rating data.
Price Target (1 analysts)
$6.00
Range $6.00 – $6.00
+412.8%
Consensus $6.00 vs current $1.17